18 Months Out of the Water: The Terbutaline File and the Name Erased from India's Swimming Team

Two names sit side by side on India's swimming roster for the 2026 Asian Games: same surname, near-identical spelling, same year of birth, same family. One stays. One disappears. No press release, no briefing, not a single explanatory line. The Swimming Federation of India simply removed a name from a list — the second time in six months. The first removal came on the Commonwealth Games roster for Glasgow. The second came on the Asian Games roster for Japan.

For a federation, deleting a name is a thirty-second administrative action. For a seventeen-year-old swimmer, it erases an entire season.

The swimmer has not been formally named because he is a minor. The Times of India and several domestic outlets were forced into circumlocution: the suspended swimmer has a twin brother who remains on the Asian Games team. Across the whole Indian swimming system, exactly one person fits that description.

The sample returned an adverse finding in February 2026. The substance was terbutaline. Nobody disputes that he took the medication. What is disputed is a piece of paper.

Numbers do not lie, but the people reading numbers do.

India holds roughly 1.4 billion people, the largest population on earth. Its Olympic output does not match that scale: at Paris 2026, the Indian delegation won six medals and no golds. Swimming is a sport where India has never reached a global podium. An Asian Games berth is therefore not a small matter inside that sporting ecosystem. It is a once-every-four-years opportunity and, for a seventeen-year-old, the first of the very few such windows he will get.

The 2026 Asian Games take place in Aichi and Nagoya, Japan. Rosters must be locked before the opening ceremony, and the SFI locked its roster without his name. Earlier, the federation had also withdrawn him from the Commonwealth Games roster for Glasgow, held in mid-2026. Two withdrawals, two silences. The media only connected the two events once the February sample was confirmed.

People inside swimming understand that a provisional suspension normally takes effect as soon as the B sample is confirmed. His absence from Glasgow was not a coaching decision. It was the administrative consequence of a process that had started at the beginning of the year — a process with no pause button.

He had qualified in two events for the Asian Games. Two events. For a seventeen-year-old in a country where international-standard competition pools can be counted on two hands, two berths represent years of accumulated hours: 4:30 a.m. sessions and dryland afternoons.

To understand how a paper failure can erase a competitive berth, you have to understand the substance.

Terbutaline is a beta-2 agonist, a bronchodilator class prescribed for patients with asthma, emphysema, bronchitis and other obstructive lung diseases, per the Mayo Clinic. On the World Anti-Doping Agency Prohibited List, the beta-2 agonist class sits under section S3 and is banned both in and out of competition. That detail matters: he was not merely caught on a competition day. The substance sat in his body on every day of the year.

What makes this file unusual is a technical detail outsiders rarely notice. WADA permits certain beta-2 agonists by inhalation up to defined dose thresholds with no exemption paperwork at all — salbutamol, formoterol and salmeterol all fall into that group. Terbutaline does not. To use it legally, an athlete needs a Therapeutic Use Exemption, a TUE.

This is the boundary most spectators never see. Same asthma medication. Same inhaler. But one drug lets an athlete inhale before a race without a single document, and the other does not. The distinction is not about health risk to the athlete. It is about the potential for performance enhancement. Terbutaline sits in the more tightly controlled group, and every national-level swimmer is told so at least once a year.

The TUE process is no minor administrative formality. Under the international TUE standard, an athlete ordinarily must file at least thirty days before competition, attaching medical history, respiratory function test results and a specialist's opinion. The application is reviewed by an independent panel, not by the national federation. The SFI has no approval power whatsoever. It only has the power to make sure its athletes know the paperwork exists.

According to the Times of India, the swimmer suffered smoke inhalation, took the medication with a doctor's approval, but did not properly obtain a TUE. He did declare the substance on his doping control form. That declaration matters more than it appears. An athlete intent on cheating does not personally write a banned substance onto a form he signs himself. Declaring it is a data point, and that data point leans toward administrative oversight rather than a concealment plan.

The arithmetic of the sanction tells the story better than any press release. The standard period for a violation involving the presence of a prohibited substance in a sample is four years. That drops to two years if the panel concludes the athlete did not act intentionally. From the two-year base, the period can be reduced further depending on the degree of fault the athlete can establish, with a floor set by the rules. The final number here: eighteen months.

Eighteen months sits between two years and one year. It signals that the panel accepted the medical narrative and accepted the absence of intent, while still finding a degree of fault — for failing to complete a procedure he or his handlers should have known about. Nobody at national-team level is unaware of TUEs. A seventeen-year-old, however, might be, and that is precisely what the panel had to weigh: punishing carelessness without crushing a child for the carelessness of adults.

The SFI requested an expedited hearing, which took place last week. The motive was obvious: a dropped case would clear him to travel to Japan. The outcome was not what the federation wanted. Eighteen months was handed down, and the final roster again carried no trace of him. Expedited hearings normally happen only when the competition calendar creates urgency. Here, the urgency was the Asian Games. The federation tried, and that deserves to be recorded fairly.

The biggest data problem in this file is not the urine sample. It is the name. Two twin brothers competed internationally at junior level under near-identical names. Performance databases — including those considered authoritative — routinely attribute one brother's results to the other. The Times of India acknowledges this makes it nearly impossible to separate their records.

From a data analyst's perspective, this is an expensive silent error. No error message, no red cell. Just one wrong row sitting quietly in a table, and every model built on top of it is wrong by extension. When a scout from another federation feeds one brother's data into a talent model, nobody knows who is being evaluated, whose regression line is being compared to whose.

I once worked with a junior Asian swimming dataset for several months. Name-error rates at junior meets vary widely between countries, and the hardest errors to detect involve siblings competing in the same events, because every secondary identifier — birth year, club, nationality, gender — matches. Only one variable separates them, and that variable is usually abbreviated to fit a spreadsheet cell.

There is a bitter irony here. Protecting a minor's identity is correct and necessary. But when that minor has a twin brother still competing, the protection inadvertently turns the brother into the default suspect in the public eye. Any reader can assemble the name. Two children born in the same house, and only one is shielded by the silence.

I have followed swimming since 2026, when I was the swimming correspondent at Thanh Niên Báo. I learned something there that has stayed with me through my career: in sports measured in seconds, the real story always lives in the data nobody bothers to print. A results sheet prints names and times. It does not print whether that athlete filed a Therapeutic Use Exemption, whether it was filed on time, or whether anyone at the federation read the file before signing off.

In 2026, at the World Cup in Russia, I refused to edit my piece to call the host nation's win over Spain a "miracle." The data showed Russia pressing proactively at a PPDA of 8.7 while goalkeeper Akinfeev saved six shots. A miracle is just a data point that has not been regressed yet. I kept my conclusion, the piece drew 1.2 million views, and a fair amount of argument along with it.

I mention that because today's file is also producing a miracle narrative: a seventeen-year-old crushed by the system over a single sheet of paper. That story is compelling, and it is partly true. But the data does not permit stopping there, and I do not have the habit of stopping where it is comfortable.

India is the world's most populous nation and one of the sports systems with the highest number of anti-doping rule violations on the planet for several consecutive years. WADA publishes ADRV figures annually, and India consistently ranks among the leaders in case counts. At Paris 2026, India won six medals and no golds.

Placing two data points side by side does not create causation. That is the first thing I have to say, and I say it seriously.

The media's first reflex is cultural attribution. "India cheats" is the easiest sentence to write and the least informative one. Break India's ADRV figures down by sport, by level and by substance class, and a different picture emerges: most cases involve substances banned for therapeutic purposes rather than performance-enhancing drugs, and case rates at junior level run far higher than at elite level — where each delegation has dedicated medical staff and someone whose job is to approve paperwork.

The conclusion that follows is not about morality. It is about administrative infrastructure. An athlete with genuine lung disease and a genuine prescription, inside a system with nobody responsible for TUEs, has a rational incentive to skip the procedure. Skipping the procedure did not make him swim a single second faster. It cost him eighteen months.

This is the paradox at the heart of the file. At therapeutic thresholds, terbutaline is not a substance that produces large performance differences in swimming. Yet it produced a sanction far heavier than its actual effect. Sanctions do not measure a substance's effect. They measure procedural compliance, and procedural compliance depends on whether a federation has anyone who knows how to read the procedure.

One more thing: eighteen months is not a light sanction, however it sounds. It erases the 2026 Asian Games. It erases most of 2027 — the most important stretch in a swimmer's development between seventeen and nineteen. Swimming peaks are usually reached between twenty and twenty-four. Eighteen silent months is a gap spanning nearly half an Olympic cycle, and no training centre fills that gap with a programme.

And the last thing nobody wants to say: the data on this swimmer, even after his return, will remain contaminated by the name problem. Every scouting file on him will need a cross-check note attached. That is a data tax he pays for the rest of his career, for an error he did not cause.

If the sanction is calculated from the sample collection date or from the provisional suspension in early 2026, the eighteen months expire around mid-2027. The next stop after that is qualification for the Los Angeles 2028 Olympics. He will be twenty.

Twenty is old enough to understand why people need a piece of paper.

The question for the SFI is not whether he deserves to come back. The question is whether, over the next eighteen months, the federation builds a dedicated TUE unit — so that no other seventeen-year-old pays for a procedure nobody ever taught him to complete.

Data only dies when we stop asking questions. I do not believe in luck; I believe in the margin of error. Every shock has a portrait in old data — including the shock of a name erased from a list that nobody bothered to explain.